Takeda Hit With $2.3M Verdict In Philly Actos Case
Takeda Pharmaceuticals Inc. was hit with a $2.3 million verdict on Thursday after a Philadelphia jury concluded that the diabetes drug Actos had been a significant cause of a retired Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article